$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold

$fold Overview Financials Valuation SEC Filings Company Website

2013 Q1 Form 10-K Financial Statement

#000104746913002611 Filed on March 13, 2013

Income Statement

Concept	2013 Q1	2011 Q4	2011 Q3
Revenue	$0.00	$5.630M	$5.798M
YoY Change	-100.0%	511.96%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.820M	$3.920M	$4.840M
YoY Change	17.56%	2.62%	24.42%
% of Gross Profit
Research & Development	$11.99M	$14.40M	$13.71M
YoY Change	-14.39%	9.51%	54.75%
% of Gross Profit
Depreciation & Amortization	$440.0K	$350.0K	$380.0K
YoY Change	4.76%	-27.08%	-25.49%
% of Gross Profit
Operating Expenses	$17.25M	$18.66M	$18.93M
YoY Change	-6.85%	6.87%	42.67%
Operating Profit	-$17.25M		-$13.13M
YoY Change	60.55%
Interest Expense	$10.00K	$740.0K	$32.00K
YoY Change	-76.74%	-176.29%	-101.53%
% of Operating Profit
Other Income/Expense, Net	$0.00	$0.00	$0.00
YoY Change		-100.0%
Pretax Income	-$17.46M	-$12.29M	-$9.759M
YoY Change	32.89%	-24.28%	-36.46%
Income Tax	$0.00	-$3.630M	$0.00
% Of Pretax Income
Net Earnings	-$17.46M	-$8.662M	-$9.759M
YoY Change	32.89%	-42.6%	-36.46%
Net Earnings / Revenue		-153.85%	-168.32%
Basic Earnings Per Share
Diluted Earnings Per Share	-$351.9K	-$250.0K	-$279.0K
COMMON SHARES
Basic Shares Outstanding	49.63M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q1	2011 Q4	2011 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$84.80M	$55.70M	$69.50M
YoY Change	-21.63%	-48.14%	20.66%
Cash & Equivalents	$26.74M	$25.67M	$22.81M
Short-Term Investments	$58.00M	$30.00M	$46.70M
Other Short-Term Assets	$1.753M	$5.903M	$3.000M
YoY Change	-37.15%	168.32%	3.45%
Inventory
Prepaid Expenses
Receivables	$1.300M
Other Receivables	$0.00
Total Short-Term Assets	$87.81M	$66.65M	$76.40M
YoY Change	-23.83%	-39.25%	26.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.962M	$2.438M	$1.800M
YoY Change	-2.19%	-6.23%	-40.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$442.0K	$709.0K	$700.0K
YoY Change	0.0%	136.33%	133.33%
Total Long-Term Assets	$5.404M	$3.147M	$2.500M
YoY Change	-2.01%	8.52%	-24.24%
TOTAL ASSETS
Total Short-Term Assets	$87.81M	$66.65M	$76.40M
Total Long-Term Assets	$5.404M	$3.147M	$2.500M
Total Assets	$93.22M	$69.80M	$78.90M
YoY Change	-22.84%	-38.02%	23.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$6.400M	$2.576M	$8.100M
YoY Change	-23.81%	-68.96%	19.12%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$400.0K	$1.000M	$1.300M
YoY Change	-63.64%	-23.08%	0.0%
Total Short-Term Liabilities	$7.995M	$19.26M	$18.60M
YoY Change	-55.0%	18.86%	129.63%
LONG-TERM LIABILITIES
Long-Term Debt	$200.0K	$0.00	$100.0K
YoY Change	-66.67%	-100.0%	-92.86%
Other Long-Term Liabilities	$31.70M	$20.90M	$23.30M
YoY Change	46.08%	-31.25%	513.16%
Total Long-Term Liabilities	$31.90M	$20.90M	$23.40M
YoY Change	43.05%	-33.44%	350.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.995M	$19.26M	$18.60M
Total Long-Term Liabilities	$31.90M	$20.90M	$23.40M
Total Liabilities	$39.90M	$40.20M	$42.10M
YoY Change	-0.25%	-15.55%	216.54%
SHAREHOLDERS EQUITY
Retained Earnings	-$336.3M	-$270.1M
YoY Change	18.75%
Common Stock	$389.7M	$299.7M
YoY Change	7.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$53.34M	$29.59M	$36.80M
YoY Change
Total Liabilities & Shareholders Equity	$93.22M	$69.80M	$78.90M
YoY Change	-22.84%	-38.02%	23.67%

Cashflow Statement

Concept	2013 Q1	2011 Q4	2011 Q3
OPERATING ACTIVITIES
Net Income	-$17.46M	-$8.662M	-$9.759M
YoY Change	32.89%	-42.6%	-36.46%
Depreciation, Depletion And Amortization	$440.0K	$350.0K	$380.0K
YoY Change	4.76%	-27.08%	-25.49%
Cash From Operating Activities	-$13.90M	-$12.52M	-$12.99M
YoY Change	72.89%	-155.97%	17.45%
INVESTING ACTIVITIES
Capital Expenditures	$372.0K	-$1.020M	-$220.0K
YoY Change	-87.93%	466.67%	266.67%
Acquisitions
YoY Change
Other Investing Activities	$7.140M	$16.71M	$10.53M
YoY Change	-113.32%	-139.38%	17.39%
Cash From Investing Activities	$6.770M	$15.69M	$10.31M
YoY Change	-111.94%	-136.81%	15.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-100.0K	-310.0K	-300.0K
YoY Change	-100.16%	-101.12%	-18.92%
NET CHANGE
Cash From Operating Activities	-13.90M	-12.52M	-12.99M
Cash From Investing Activities	6.770M	15.69M	10.31M
Cash From Financing Activities	-100.0K	-310.0K	-300.0K
Net Change In Cash	-7.230M	2.860M	-2.980M
YoY Change	528.7%	-61.76%	18.25%
FREE CASH FLOW
Cash From Operating Activities	-$13.90M	-$12.52M	-$12.99M
Capital Expenditures	$372.0K	-$1.020M	-$220.0K
Free Cash Flow	-$14.27M	-$11.50M	-$12.77M
YoY Change	28.32%	-151.0%	16.09%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Investment Income Interest InvestmentIncomeInterest	14389000	USD
CY2012	us-gaap	Interest Expense InterestExpense	89000	USD
	us-gaap	Interest Expense InterestExpense	2422000	USD
CY2012	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	21000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	252000	USD
CY2012	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3245000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8708000	USD
CY2012	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	50273000	USD
	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	315893000	USD
CY2012	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19364000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	132613000	USD
CY2012	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1705000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11768000	USD
CY2012	us-gaap	Investment Income Interest InvestmentIncomeInterest	316000	USD
CY2012Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	908000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	556000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	387539000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14000	USD
CY2012	fold	Research Revenue ResearchRevenue	11591000	USD
	fold	Research Revenue ResearchRevenue	57493000	USD
	fold	Collaboration Revenue CollaborationRevenue	64382000	USD
CY2012	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.07
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	14000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-71000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	32000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	10000	USD
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	14000	USD
CY2010	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-71000	USD
CY2011	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	32000	USD
CY2012	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	14000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-318875000	USD
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	0	USD
CY2012	us-gaap	Share Based Compensation ShareBasedCompensation	6191000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	41929000	USD
CY2012	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-653000	USD
	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-1553000	USD
CY2012	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-28000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-388000	USD
CY2012	fold	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	387000	USD
CY2012	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	83352000	USD
CY2011	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-3629000	USD
CY2010	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1252000	USD
CY2012	dei	Document Period End Date DocumentPeriodEndDate	2012-12-31
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	755442000	USD
CY2012	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	118459000	USD
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	820695000	USD
CY2012	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4324000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	18213000	USD
CY2012	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	80195000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	193441000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	5587000	USD
CY2012	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1342000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	4056000	USD
CY2012	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1630000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3341000	USD
	fold	Proceeds From Exercise Of Warrants Common And Preferred ProceedsFromExerciseOfWarrantsCommonAndPreferred	264000	USD
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	5611000	USD
CY2012	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	62055000	USD
	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	4753000	USD
CY2012	us-gaap	Interest Paid InterestPaid	84000	USD
CY2012	fold	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	500000	shares
CY2012	dei	Entity Registrant Name EntityRegistrantName	AMICUS THERAPEUTICS INC
CY2012	dei	Entity Central Index Key EntityCentralIndexKey	0001178879
CY2012	dei	Document Type DocumentType	10-K
CY2012	dei	Amendment Flag AmendmentFlag	false
CY2012	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2012	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2012	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2012	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2012	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2012Q2	dei	Entity Public Float EntityPublicFloat	104283867	USD
CY2013Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49631672	shares
CY2012	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2012
CY2012	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2012Q4	us-gaap	Warrants Not Settleable In Cash Fair Value Disclosure WarrantsNotSettleableInCashFairValueDisclosure	900000	USD
CY2012	fold	Class Of Warrants Or Rights Value Exercised ClassOfWarrantsOrRightsValueExercised	300000	USD
CY2010Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	4950000	shares
CY2012Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	62000000	USD
CY2010Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	1900000	shares
CY2012Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	11500000	shares
CY2010Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17100000	USD
CY2012	us-gaap	Use Of Estimates UseOfEstimates	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <ul> <li style="list-style: none"> <p style="FONT-FAMILY: times"><font size="2"><b><i>Use of Estimates</i></b></font></p></li></ul> <p style="FONT-FAMILY: times"><font size="2">        The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></p></div>
CY2012	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style='font-size:10.0pt;FONT-FAMILY: Times New Roman;'> <ul> <li style="list-style: none"> <p style="FONT-FAMILY: times"><font size="2"><b><i>Concentration of Credit Risk</i></b></font></p></li></ul> <p style="FONT-FAMILY: times"><font size="2">        The Company's financial instruments that are exposed to concentration of credit risk consist primarily of cash and cash equivalents and marketable securities. The Company maintains its cash and cash equivalents in bank accounts, which, at times, exceed federally insured limits. The Company invests its marketable securities in high-quality commercial financial instruments. The Company has not recognized any losses from credit risks on such accounts during any of the periods presented. The Company believes it is not exposed to significant credit risk on cash and cash equivalents or its marketable securities.</font></p></div>
CY2012Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	33971000	USD
CY2012	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
CY2012Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	65151000	USD
CY2010	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27734797	shares
CY2011	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	34569642	shares
CY2012	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	45565217	shares
CY2012Q4	fold	Share Based Compensation Number Of Plans ShareBasedCompensationNumberOfPlans	3	item
CY2010	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6200000	USD
CY2011	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8700000	USD
CY2012	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6200000	USD
CY2010	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-54936000	USD
CY2011	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-44412000	USD
CY2012	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-48785000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33971000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	25668000	USD
CY2011Q4	fold	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	55702000	USD
CY2012Q4	fold	Cash Cash Equivalents And Short Term Investments Fair Value Disclosure CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure	99122000	USD
CY2012Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	65137000	USD
CY2011Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	55698000	USD
CY2012Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	99108000	USD
CY2011Q4	us-gaap	Availableforsale Securities Gross Unrealized Gain AvailableforsaleSecuritiesGrossUnrealizedGain	12000	USD
CY2012Q4	us-gaap	Available For Sale Securities Gross Unrealized Losses1 AvailableForSaleSecuritiesGrossUnrealizedLosses1	11000	USD
CY2011Q4	us-gaap	Available For Sale Securities Fair Value Disclosure AvailableForSaleSecuritiesFairValueDisclosure	30034000	USD
CY2011Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	30030000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	32000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	10000	USD
CY2011Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	13200000	USD
CY2012Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	33100000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13530000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	11945000	USD
CY2010	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.08	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.13	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.03	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.51	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.03	pure
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.04	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits Research EffectiveIncomeTaxRateReconciliationTaxCreditsResearch	0.08	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.02	pure
CY2010	fold	Income Tax Expenses Benefit From Sale Of Net Operating Losses And Research And Development Credits IncomeTaxExpensesBenefitFromSaleOfNetOperatingLossesAndResearchAndDevelopmentCredits	1100000	USD
CY2010	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.07	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.34	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.38	pure
CY2010	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.02	pure
CY2011	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.08	pure
CY2012	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.06	pure
CY2011Q1	us-gaap	Net Income Loss NetIncomeLoss	-13350000	USD
CY2011Q2	us-gaap	Net Income Loss NetIncomeLoss	-12641000	USD
CY2011Q3	us-gaap	Net Income Loss NetIncomeLoss	-9759000	USD
CY2011Q4	us-gaap	Net Income Loss NetIncomeLoss	-8662000	USD
CY2012Q1	us-gaap	Net Income Loss NetIncomeLoss	-13137000	USD
CY2012Q2	us-gaap	Net Income Loss NetIncomeLoss	-9343000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-16290000	USD
CY2012Q4	us-gaap	Net Income Loss NetIncomeLoss	-10015000	USD
CY2011Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2011Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2011Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.28
CY2011Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2012Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.35
CY2012Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.34
CY2012Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.20
CY2012	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	2915000	USD
CY2011Q4	fold	Accrued Facilities Consolidation Current AccruedFacilitiesConsolidationCurrent	38000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	30418000	USD
CY2010	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	32279000	USD
CY2011	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4776000	USD
CY2011Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9507000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	8501000	USD
CY2011Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2438000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5029000	USD
CY2011Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2576000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2115000	USD
CY2011Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	215000	USD
CY2011Q4	fold	Accrued Contract Manufacturing And Contract Research Costs Current AccruedContractManufacturingAndContractResearchCostsCurrent	3489000	USD
CY2011Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3162000	USD
CY2011Q4	fold	Accrued Facility Costs Current AccruedFacilityCostsCurrent	27000	USD
CY2011Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	201000	USD
CY2011Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	9708000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	409000	USD
CY2012Q4	fold	Accrued Contract Manufacturing And Contract Research Costs Current AccruedContractManufacturingAndContractResearchCostsCurrent	1743000	USD
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	4229000	USD
CY2012Q4	fold	Accrued Facility Costs Current AccruedFacilityCostsCurrent	167000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	182000	USD
CY2012Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	8845000	USD
CY2012	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	3300000	USD
CY2012	fold	Fair Value Inputs Number Of Inputs Used In Fair Value Classification FairValueInputsNumberOfInputsUsedInFairValueClassification	6	item
CY2012	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-653000	USD
CY2010	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	1400000	USD
CY2011	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-2800000	USD
CY2008Q4	fold	Operating Leases Option To Extend Number Of Lease Term OperatingLeasesOptionToExtendNumberOfLeaseTerm	2	item
CY2008	fold	Operating Leases Extended Term Of Lease Agreement OperatingLeasesExtendedTermOfLeaseAgreement	P5Y
CY2012	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease	-700000	USD
CY2012	us-gaap	Defined Contribution Plan Maximum Annual Contribution Per Employee Percent DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent	0.05	pure
CY2012	fold	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P1Y
CY2010	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	400000	USD
CY2011	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	600000	USD
CY2012	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	USD
CY2010Q1	fold	Number Of Warrants Sold In One Unit NumberOfWarrantsSoldInOneUnit	1	shares
CY2011Q4	fold	Deferred Tax Assets Non Cash Stock Issue Current DeferredTaxAssetsNonCashStockIssueCurrent	6745000	USD
CY2011Q4	fold	Deferred Tax Assets Other Current DeferredTaxAssetsOtherCurrent	662000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	7407000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3791000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	4325000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	48930000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	10985000	USD
CY2011Q4	fold	Deferred Tax Assets Other Noncurrent DeferredTaxAssetsOtherNoncurrent	-236000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	75202000	USD
CY2011Q4	fold	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	75202000	USD
CY2011Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	75202000	USD
CY2011	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	6700000	USD
CY2012Q4	fold	Deferred Tax Assets Non Cash Stock Issue Current DeferredTaxAssetsNonCashStockIssueCurrent	7100000	USD
CY2012	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	20100000	USD
CY2012Q4	fold	Deferred Tax Assets Other Current DeferredTaxAssetsOtherCurrent	1257000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	8357000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	3176000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	9072000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	62060000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	12149000	USD
CY2012Q4	fold	Deferred Tax Assets Other Noncurrent DeferredTaxAssetsOtherNoncurrent	520000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	95334000	USD
CY2012	fold	Operating Loss Carryforwards Limitations On Use Minimum Ownership Percentage Change Relating To Section382 OperatingLossCarryforwardsLimitationsOnUseMinimumOwnershipPercentageChangeRelatingToSection382	0.50	pure
CY2012	fold	Operating Loss Carryforwards Limitations On Use Minimum Percentage Ownership Change Period OperatingLossCarryforwardsLimitationsOnUseMinimumPercentageOwnershipChangePeriod	P3Y
CY2010	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	-0.34	pure
CY2011	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	-0.34	pure
CY2012	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	-0.34	pure
CY2011Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2012Q4	fold	Common Stock Voting Rights For Each Share Held CommonStockVotingRightsForEachShareHeld	1	item
CY2010Q1	fold	Stock Issued During Period Shares Collaboration Agreement StockIssuedDuringPeriodSharesCollaborationAgreement	4900000	shares
CY2012Q1	us-gaap	Share Price SharePrice	5.70
CY2012Q1	fold	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	65600000	USD
CY2010Q1	fold	Number Of Shares Of Common Stock Sold In One Unit NumberOfSharesOfCommonStockSoldInOneUnit	1	shares
CY2010Q1	fold	Portion Of Share Purchased In One Unit PortionOfSharePurchasedInOneUnit	0.375	shares
CY2010Q1	us-gaap	Share Price SharePrice	3.74
CY2010Q1	fold	Warrant Term WarrantTerm	P4Y
CY2010Q1	fold	Exercise Period Of Warrant On Or After Issued ExercisePeriodOfWarrantOnOrAfterIssued	P6M
CY2010Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights	4.43
CY2010	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2300000	USD
CY2010Q1	fold	Proceeds From Issuance Of Common Stock Gross ProceedsFromIssuanceOfCommonStockGross	18500000	USD
CY2011	fold	Additional Allocated Share Based Compensation Expense AdditionalAllocatedShareBasedCompensationExpense	2700000	USD
CY2012	fold	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsVolatilityRateMinimum	0.75	pure
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1735000	USD
CY2012Q4	fold	Operating Leases Future Minimum Payments Due In Five Years And Thereafter OperatingLeasesFutureMinimumPaymentsDueInFiveYearsAndThereafter	3844000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	10502000	USD
CY2011Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	73646
CY2011	fold	Operating Leases Initial Term Of Lease Agreement OperatingLeasesInitialTermOfLeaseAgreement	P7Y
CY2011Q4	fold	Operating Leases Option To Extend Number Of Lease Term OperatingLeasesOptionToExtendNumberOfLeaseTerm	2	item
CY2011	fold	Operating Leases Extended Term Of Lease Agreement OperatingLeasesExtendedTermOfLeaseAgreement	P5Y
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	1749000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1540000	USD
CY2012Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1634000	USD
CY2011	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2300000	USD
CY2012	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	2600000	USD
CY2012Q4	us-gaap	Secured Debt SecuredDebt	697000	USD
CY2012Q4	us-gaap	Assets Assets	110088000	USD
CY2012Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	299000	USD
CY2010	us-gaap	Net Income Loss NetIncomeLoss	-54936000	USD
CY2011	us-gaap	Net Income Loss NetIncomeLoss	-44412000	USD
	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	1030000	USD
CY2010	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.98
CY2011	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.28
CY2011	fold	Income Tax Expenses Benefit From Sale Of Net Operating Losses And Research And Development Credits IncomeTaxExpensesBenefitFromSaleOfNetOperatingLossesAndResearchAndDevelopmentCredits	3600000	USD
CY2012	fold	Income Tax Expenses Benefit From Sale Of Net Operating Losses And Research And Development Credits IncomeTaxExpensesBenefitFromSaleOfNetOperatingLossesAndResearchAndDevelopmentCredits	3200000	USD
CY2012	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	-1818000	USD
CY2011Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	30034000	USD
CY2011Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	5043000	USD
CY2011Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5903000	USD
CY2011Q4	us-gaap	Assets Current AssetsCurrent	66648000	USD
CY2011Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	709000	USD
CY2011Q4	us-gaap	Assets Assets	69795000	USD
CY2011Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	1044000	USD
CY2011Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19256000	USD
CY2011Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1948000	USD
CY2011Q4	us-gaap	Common Stock Value CommonStockValue	407000	USD
CY2011Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	299285000	USD
CY2011Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	4000	USD
CY2010	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-19442000	USD
CY2012	us-gaap	Sales Revenue Net SalesRevenueNet	18411000	USD
CY2012	us-gaap	Operating Expenses OperatingExpenses	71342000	USD
CY2012	us-gaap	Operating Income Loss OperatingIncomeLoss	-52931000	USD
CY2011	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19880000	USD
CY2012	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3633000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	104617000	USD
CY2011Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2270000	USD
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2012	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-267000	USD
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	125000000	shares
CY2011Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34654206	shares
CY2011Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34654206	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49631672	shares
	fold	Deemed Dividend DeemedDividend	19424000	USD
CY2011Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-270104000	USD
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	29592000	USD
CY2011Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	69795000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	110088000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	69220000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2011Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	9243000	USD
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49631672	shares
	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	3225000	USD
CY2011	fold	Research Revenue ResearchRevenue	14794000	USD
CY2010	fold	Collaboration Revenue CollaborationRevenue	922000	USD
CY2011	fold	Collaboration Revenue CollaborationRevenue	6640000	USD
CY2010	us-gaap	Sales Revenue Net SalesRevenueNet	922000	USD
CY2011	us-gaap	Sales Revenue Net SalesRevenueNet	21434000	USD
CY2010	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	39042000	USD
CY2011	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	50856000	USD
CY2010	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	15660000	USD
CY2010	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2058000	USD
CY2011	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1585000	USD
	fold	Preferred Stock Accretion PreferredStockAccretion	802000	USD
	us-gaap	Research And Development In Process ResearchAndDevelopmentInProcess	418000	USD
CY2010	us-gaap	Operating Expenses OperatingExpenses	56760000	USD
CY2011	us-gaap	Operating Expenses OperatingExpenses	72321000	USD
CY2011	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	70000	USD
CY2010	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-56075000	USD
CY2010	us-gaap	Operating Income Loss OperatingIncomeLoss	-55838000	USD
CY2011	us-gaap	Operating Income Loss OperatingIncomeLoss	-50887000	USD
CY2010	us-gaap	Investment Income Interest InvestmentIncomeInterest	156000	USD
CY2011	us-gaap	Investment Income Interest InvestmentIncomeInterest	160000	USD
CY2010	us-gaap	Interest Expense InterestExpense	260000	USD
CY2011	us-gaap	Interest Expense InterestExpense	148000	USD
CY2010	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	1410000	USD
CY2011	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-2764000	USD
CY2010	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1277000	USD
CY2011	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-48041000	USD
CY2010	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1139000	USD
CY2012	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-52030000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	121875000	USD
	us-gaap	Restructuring Charges RestructuringCharges	1522000	USD
	us-gaap	Operating Expenses OperatingExpenses	463244000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	466000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-341369000	USD
	fold	Change In Fair Value Of Warrant Liability ChangeInFairValueOfWarrantLiability	-1553000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-327597000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-339115000	USD
CY2012	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-863000	USD
	fold	Stock Based License Payments StockBasedLicensePayments	1220000	USD
	fold	Beneficial Conversion Feature Related To Bridge Financing BeneficialConversionFeatureRelatedToBridgeFinancing	135000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8845000	USD
	us-gaap	Share Based Goods And Nonemployee Services Transaction Expense ShareBasedGoodsAndNonemployeeServicesTransactionExpense	853000	USD
	us-gaap	Other Amortization Of Deferred Charges OtherAmortizationOfDeferredCharges	522000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	525000	USD
CY2010	us-gaap	Share Based Compensation ShareBasedCompensation	6186000	USD
CY2011	us-gaap	Share Based Compensation ShareBasedCompensation	8679000	USD
CY2012	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-33744000	USD
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	143022000	USD
CY2010	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	1410000	USD
CY2011	fold	Change In Fair Value Of Warrant Liability Adjustments To Reconcile Net Loss To Net Cash Used In Operating Activities ChangeInFairValueOfWarrantLiabilityAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities	-2764000	USD
CY2010	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-121000	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	5000000	USD
CY2012	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	995000	USD
CY2012	us-gaap	Net Income Loss NetIncomeLoss	-48785000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-318889000	USD
CY2009Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19339000	USD
CY2010Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29572000	USD
CY2002Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1775000	USD
CY2011	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	5043000	USD
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	11000	USD
CY2010	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-26000	USD
CY2011	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3667000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	8000	USD
CY2010	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-218000	USD
CY2011	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	442000	USD
	fold	Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value Amortization AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValueAmortization	27000	USD
CY2010	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1345000	USD
CY2011	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1418000	USD
	fold	Stock Issued For In Process Research And Development StockIssuedForInProcessResearchAndDevelopment	418000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	84000	USD
CY2010	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-13983000	USD
CY2011	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-49422000	USD
CY2010	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	94602000	USD
CY2011	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	98474000	USD
CY2010	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	113660000	USD
CY2011	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	50602000	USD
CY2010	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	384000	USD
CY2011	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1420000	USD
CY2011	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	46452000	USD
CY2010	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	45214000	USD
CY2010	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	313000	USD
CY2011	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	40000	USD
	fold	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	148951000	USD
	fold	Conversion Of Notes Payable To Preferred Stock ConversionOfNotesPayableToPreferredStock	5000000	USD
CY2006	fold	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature Deemed Dividend AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeatureDeemedDividend	19424000	USD
CY2006	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	19424000	USD
	fold	Accretion Of Redeemable Convertible Preferred Stock AccretionOfRedeemableConvertiblePreferredStock	802000	USD
CY2006	fold	Adjustments To Additional Paid In Capital Reclassification On Conversion AdjustmentsToAdditionalPaidInCapitalReclassificationOnConversion	117000	USD
CY2011	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1253000	USD
CY2010	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	9000	USD
CY2011	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	359000	USD
CY2010	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	43658000	USD
CY2011	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-934000	USD
CY2010	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	10233000	USD
CY2011	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-3904000	USD
CY2010	us-gaap	Interest Paid InterestPaid	280000	USD
CY2011	us-gaap	Interest Paid InterestPaid	149000	USD
	us-gaap	Interest Paid InterestPaid	2117000	USD
	fold	Beneficial Conversion Feature Related To Issuance Of Series C Redeemable Convertible Preferred Stock BeneficialConversionFeatureRelatedToIssuanceOfSeriesCRedeemableConvertiblePreferredStock	19424000	USD
CY2012	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	8303000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	33971000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	345789000	USD
CY2012	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	81478000	USD
CY2012	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-39431000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-83466000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-228352000	USD
CY2002Q4	us-gaap	Stockholders Equity StockholdersEquity	-1249000	USD
CY2003	us-gaap	Net Income Loss NetIncomeLoss	-6768000	USD
CY2003	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	41000	USD
CY2003	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	17000	USD
CY2003	fold	Adjustments To Additional Paid In Capital Consultant Stock Options AdjustmentsToAdditionalPaidInCapitalConsultantStockOptions	4000	USD
CY2003	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	210000	USD
CY2003	fold	Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value Amortization AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValueAmortization	70000	USD
CY2003Q4	us-gaap	Stockholders Equity StockholdersEquity	-7709000	USD
CY2004	us-gaap	Net Income Loss NetIncomeLoss	-8807000	USD
CY2004	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-9000	USD
CY2004	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	95000	USD
CY2004	fold	Adjustments To Additional Paid In Capital Convertible Debt Interest Waiver AdjustmentsToAdditionalPaidInCapitalConvertibleDebtInterestWaiver	193000	USD
CY2004	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	126000	USD
CY2004	fold	Adjustments To Additional Paid In Capital Consultant Stock Options AdjustmentsToAdditionalPaidInCapitalConsultantStockOptions	16000	USD
CY2004	fold	Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value Amortization AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValueAmortization	60000	USD
CY2004Q4	us-gaap	Stockholders Equity StockholdersEquity	-16287000	USD
CY2005	us-gaap	Net Income Loss NetIncomeLoss	-19972000	USD
CY2005	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-7000	USD
CY2005	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	139000	USD
CY2005	fold	Adjustments To Additional Paid In Capital Consultant Stock Options AdjustmentsToAdditionalPaidInCapitalConsultantStockOptions	112000	USD
CY2005	fold	Adjustments To Additional Paid In Capital Share Based Compensation Requisite Service Period Recognition Value Amortization AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRequisiteServicePeriodRecognitionValueAmortization	365000	USD
CY2005	fold	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	75000	USD
CY2005	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24000	USD
CY2005Q4	us-gaap	Stockholders Equity StockholdersEquity	-35829000	USD
CY2006	us-gaap	Net Income Loss NetIncomeLoss	-46345000	USD
CY2006	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	31000	USD
CY2006	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	159000	USD
CY2006	fold	Adjustments To Additional Paid In Capital Consultant Stock Options AdjustmentsToAdditionalPaidInCapitalConsultantStockOptions	476000	USD
CY2006	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	2816000	USD
CY2006	fold	Stock Issued During Period Value License Payment StockIssuedDuringPeriodValueLicensePayment	1220000	USD
CY2006	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	158000	USD
CY2006Q4	us-gaap	Stockholders Equity StockholdersEquity	-77515000	USD
CY2007	us-gaap	Net Income Loss NetIncomeLoss	-41167000	USD
CY2007	fold	Adjustments To Additional Paid In Capital Consultant Stock Options AdjustmentsToAdditionalPaidInCapitalConsultantStockOptions	162000	USD
CY2007	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3823000	USD
CY2007	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	458000	USD
CY2007	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	148591000	USD
CY2007	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	68145000	USD
CY2007	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	393000	USD
CY2007	fold	Adjustments To Additional Paid In Capital Warrants Charge AdjustmentsToAdditionalPaidInCapitalWarrantsCharge	758000	USD
CY2007Q4	us-gaap	Stockholders Equity StockholdersEquity	103297000	USD
CY2008	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	125000	USD
CY2008	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6446000	USD
CY2008	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	530000	USD
CY2008Q4	us-gaap	Stockholders Equity StockholdersEquity	71043000	USD
CY2009	us-gaap	Net Income Loss NetIncomeLoss	-6567000	USD
CY2009	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-490000	USD
CY2009	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	7787000	USD
CY2009	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	60000	USD
CY2009Q4	us-gaap	Stockholders Equity StockholdersEquity	71833000	USD
CY2010	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-55007000	USD
CY2010	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-71000	USD
CY2010	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6186000	USD
CY2010	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	9000	USD
CY2010	fold	Stock Issued During Period Value Collaboration Agreement StockIssuedDuringPeriodValueCollaborationAgreement	28083000	USD
CY2010	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	13830000	USD
CY2010Q4	us-gaap	Stockholders Equity StockholdersEquity	64934000	USD
CY2011	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-44380000	USD
CY2011	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	32000	USD
CY2011	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	8678000	USD
CY2011	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	360000	USD
CY2012	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-48775000	USD
CY2012	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1630000	USD
CY2012	fold	Stock Issued During Period Value Collaboration Agreement StockIssuedDuringPeriodValueCollaborationAgreement	18140000	USD
CY2012	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6191000	USD
CY2012	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	10000	USD
CY2012Q4	fold	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	95334000	USD
CY2012Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	95334000	USD
CY2012Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	65151000	USD
CY2012Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3225000	USD
CY2012Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2270000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-318889000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	442000	USD
CY2012Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	398000	USD
CY2012Q4	fold	Secured Debt Maturities Repayments Of Principal And Interest In Next Twelve Months SecuredDebtMaturitiesRepaymentsOfPrincipalAndInterestInNextTwelveMonths	398000	USD
CY2012Q4	fold	Secured Debt Maturities Repayments Of Principal And Interest In Year Two SecuredDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearTwo	299000	USD
CY2012Q4	fold	Secured Debt Maturities Repayments Of Principal And Interest In Year Three SecuredDebtMaturitiesRepaymentsOfPrincipalAndInterestInYearThree	0	USD
CY2011Q4	us-gaap	Deferred Credits And Other Liabilities Noncurrent DeferredCreditsAndOtherLiabilitiesNoncurrent	18999000	USD

Files In Submission

Name	View Source	Status
0001047469-13-002611-index-headers.html	Edgar Link	pending
0001047469-13-002611-index.html	Edgar Link	pending
0001047469-13-002611.txt	Edgar Link	pending
0001047469-13-002611-xbrl.zip	Edgar Link	pending
a2213294z10-k.htm	Edgar Link	pending
a2213294zex-23_1.htm	Edgar Link	pending
a2213294zex-31_1.htm	Edgar Link	pending
a2213294zex-31_2.htm	Edgar Link	pending
a2213294zex-32_1.htm	Edgar Link	pending
a2213294zex-32_2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
fold-20121231.xml	Edgar Link	completed
fold-20121231.xsd	Edgar Link	pending
fold-20121231_cal.xml	Edgar Link	unprocessable
fold-20121231_def.xml	Edgar Link	unprocessable
fold-20121231_lab.xml	Edgar Link	unprocessable
fold-20121231_pre.xml	Edgar Link	unprocessable
g963165.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold

2013 Q1 Form 10-K Financial Statement

#000104746913002611 Filed on March 13, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOLD AMICUS THERAPEUTICS, INC. Stock $fold

2013 Q1 Form 10-K Financial Statement

#000104746913002611 Filed on March 13, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FOLD
AMICUS THERAPEUTICS, INC. Stock $fold